Evaluation of the clinical efficacy and safety of an imidacloprid 10 %/moxidectin 2.5 % spot-on formulation (Advocate®, Advantage® Multi) in comparison to an untreated control group in dogs naturally infected by Capillaria boehmi

Autor:	Veronesi, F, DI CESARE, Angela, Braun, G, Günther, L, Morganti, G, Rueca, F, Petry, G, Schaper, R, Traversa, Donato
Jazyk:	angličtina
Rok vydání:	2017
Předmět:	Capillaria boehmi moxidectin dog Capillaria boehmi dog moxidectin
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______3664::8797ebae064167f13e0e08de549ac2d1 http://hdl.handle.net/11575/98234 Zobrazit plný text záznamu